close
This ad will auto close in 10 seconds
Cancer drug: SC allows Cipla to withdraw appeal against Roche

Cancer drug: SC allows Cipla to withdraw appeal against Roche

The Supreme Court on Friday allowed domestic drug manufacturer Cipla, which recently arrived at a settlement with Swiss pharma major Roche over a lung cancer drug, to withdraw its petition on the patent row.

Roche launches new breast cancer drugs in India

Swiss drug major Roche has launched in India two new medicines for treating breast cancer claiming increased survival benefit and improved quality of life for patients.

Italy seeks 1.2 bn euros in anti-trust damages from Roche, Novartis

Italy`s health ministry is seeking 1.2 billion euros ($1.6 million) in compensation from Swiss pharma giants Novartis and Roche for the manipulation of sales of a cheap drug used to treat eye problems, Italian media reported Wednesday.

Roche not to pursue patent for breast cancer drug in India

Swiss pharma major Roche Holding AG Friday said it won't pursue the secondary patent for its breast cancer drug 'Herceptin' in India.

Govt says Roche didn't follow norms for cancer drug patent

The government today said it had "treated as withdrawn" patent applications by Swiss pharma major Roche Holding for offshoot medicines of its breast cancer drug 'Herceptin' because the company did not comply with local norms.

Roche to slash prices of expensive cancer drugs in India

Global pharma major Roche is all set to slash the price of two expensive cancer drugs in India, as part of efforts to strengthen its position amid rising competition from generic drug makers, says a media report.